MedTrace Logo

Advanced Footwear Technology in Federated Athletes

NCT06919107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2026-05-01

No results posted yet for this study

Summary

Background. Athletics is one of the sports modalities with the greatest growth in the number of federative licenses in our country. In the last five years, the use of footwear with Advanced Footwear Technology (AFT) has become widespread in order to increase athletic performance.

Objective. To analyze the risk of injury in athletes using Advanced Footwear Technology as well as the sporting, sociodemographic and anthropometric variables that influence this risk.

Method. Ambispective cohort study. Ninety-five athletes competing in events longer than 800 meters will be recruited. The primary variable will be the number of injuries, muscular and tendon, of lower limbs in the last 3 athletic seasons. Secondary and modifying variables will be: age, sex, weekly training load with and without AFT, weekly training frequency, completion of a complementary toning program and foot size. Potential confounding variables will be body mass index, main training surface and commercial footwear models used. The analysis will calculate the risk of injury in these athletes and assess the influence of confounders and trend analysis on the primary variable, stratified by potential confounders.

Expected results. To calculate the risk of injury as a function of sport, sociodemographic and anthropometric variables. Identify

Conditions

  • Athlete Foot

Interventions

OTHER

Survey of athletes

Data will be collected on the number of injuries (muscle and tendon), lower limb injuries in the last 3 athletic seasons, as well as age, sex, weekly training load with and without AFT, weekly training frequency, completion of a complementary toning program and foot size.

Sponsors & Collaborators

  • University of Oviedo

    lead OTHER

Principal Investigators

  • Rubén Cuesta-Barriuso, PhD · Universidad de Oviedo

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2025-04-30
Completion
2025-05-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06919107 on ClinicalTrials.gov